Insight into loss processes in perovskite solar cells enables efficiency improvements

The analysed perovskite cell has a surface of 1 cm<sup>2</sup>. Credit. Uni Potsdam

The analysed perovskite cell has a surface of 1 cm2. Credit. Uni Potsdam © Uni Potsdam

With additional layers between the perovskite semiconductor and the hole- and electron-transportlayers (red and blue lines), the team at the University of Potsdam was able to further increase efficiency of the perovskite cell. Bild. Uni Potsdam

With additional layers between the perovskite semiconductor and the hole- and electron-transportlayers (red and blue lines), the team at the University of Potsdam was able to further increase efficiency of the perovskite cell. Bild. Uni Potsdam © Uni Potsdam

In perovskite solar cells, charge carriers are mainly lost through recombination occurring at interface defect sites. In contrast, recombination at defect sites within the perovskite layer does not limit the performance of the solar cells at present. Teams from the University of Potsdam and the Helmholtz-Zentrum Berlin (HZB) were able to reach this interesting conclusion through extremely accurate quantitative measurements on 1 cm2 perovskite cells using photoluminescence. Their results contribute to improving  perovskite solar cells and have now been published in Nature Energy.

Even solar cells made of a perfect miracle material would never be able to convert 100 % of sunlight to electrical energy. This is because the theoretical maximum achievable power is limited by the position of the energy bands of the electrons, and by unavoidable radiation of photons (the thermodynamic or Shockley-Queisser limit). Maximum power conversion efficiency for silicon is about 33 %, for example. But even this value will never actually be reached. This is due to defects of various kinds causing the loss of some of the charge carriers released by sunlight. In order to approach the maximum value, it is therefore necessary to investigate the various defects in solar cells and determine which ones lead to losses and how.

Organometallic perovskite absorber layers are regarded as a particularly exciting new material class for solar cells – in just ten years, their efficiency has increased from three per cent to over twenty per cent, an amazing success story. Now a team headed by Prof. Dr. Dieter Neher at the University of Potsdam and Dr. Thomas Unold at HZB has succeeded in identifying the decisive loss processes in perovskite solar cells that limit the efficiency.

At certain defects in the crystal lattice of the perovskite layer, charge carriers (i.e. electrons and “holes“) that have just been released by sunlight can recombine again and thus be lost. But whether these defects were preferentially located within the perovskite layer, or instead at the interface between the perovskite layer and the transport layer was unclear until now.

To determine this, the scientists employed photoluminescence techniques with high precision, spatial and temporal resolution. Using laser light, they excited the square-centimetre-sized perovskite layer and detected where and when the material emitted light in response to the excitation. “This measurement method at our lab is so precise, we can determine the exact number of photons that have been emitted”, explains Unold. And not only that, the energy of the emitted photons was precisely recorded and analyzed as well using a hyperspectral CCD camera.

“In this way, we were able to calculate the losses at every point of the cell and thereby determine that the most harmful defects are located at the interfaces between the perovskite absorber layer and the chargetransport layers“, reports Unold. This is important information for further improving perovskite solar cells, for instance by means of intermediate layers that have a positive effect or through modified fabrication methods.

With the help of these findings, the group led by Prof. Dr. Dieter Neher and Dr. Martin Stolterfoht at the University of Potsdam has succeeded in reducing interfacial recombination and thus increasing the efficiency of 1cm2sized perovskite solar cells to well over 20 %.

Published in Nature Energy (2018):Visualization and suppression of interfacial recombination for high-efficiency large-area pin perovskite solar cells; Martin Stolterfoht, Christian M. Wolff, José A. Márquez, Shanshan Zhang,Charles J. Hages,Daniel Rothhardt, Steve Albrecht, Paul L. Burn, Paul Meredith, Thomas Unold and Dieter Neher
Doi:10.1038/s41560-018-0219-8

arö

  • Copy link

You might also be interested in

  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography. 
  • Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    News
    02.03.2026
    Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    Alexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
  • 5000th protein structure at BESSY II: Starting point for a COVID drug
    Science Highlight
    26.02.2026
    5000th protein structure at BESSY II: Starting point for a COVID drug
    Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.